Introduction {#Sec1}
============

Pulsed low intensity ultrasound (PLIUS), also known as low intensity pulsed ultrasound (LIPUS), has clinically been shown to enhance the healing of fresh fractures and bony non-unions \[[@CR16], [@CR22]\]. The mode of action is unclear, although exciting new studies indicate that ultrasound activates the canonical Wnt signalling pathway which is important for osteoblast function \[[@CR34]\]. Other studies suggest that ultrasound may stimulate bone healing processes such as endochondral ossification \[[@CR37], [@CR41]\], involving the earlier expression of cartilage specific genes \[[@CR44]\]. Consequently, PLIUS may also be beneficial for cartilage regeneration either in vivo or as part of an in vitro tissue engineered approach \[[@CR6], [@CR17], [@CR29]\].

The acoustic pressure waves produced by PLIUS can be considered as high-frequency micromechanical perturbations that may have a direct mechanical effect on exposed cells. Indeed, the resulting cellular and intracellular changes may be similar to those seen with more physiological low frequency cyclic compression of chondrocytes in cartilage explants \[[@CR12]\] or biomaterial scaffolds \[[@CR5], [@CR24], [@CR28]\]. Several in vitro studies have been undertaken to characterise the effects of PLIUS on chondrocytes in both monolayer and 3D model systems. These studies report upregulation of aggrecan and collagen II genes \[[@CR30], [@CR35], [@CR45]\], GAG synthesis \[[@CR20], [@CR32]\], calcium signalling \[[@CR36]\], and integrin expression \[[@CR18]\]. However, conflicting reports suggest that PLIUS induces, at best, a transient effect on chondrocyte culture systems in terms of aggrecan gene expression \[[@CR46]\], and GAG and collagen II production \[[@CR17], [@CR21]\]. Furthermore, a study involving the implantation of a tissue-engineered scaffold into nude mice indicated that PLIUS had no effect on cartilage matrix production, as assessed by histological staining, and an inhibitory effect on neocartilage maturation in terms of collagen II gene expression and tissue biomechanics \[[@CR10]\]. The literature is therefore ambiguous regarding the influence of PLIUS on articular chondrocytes and the possible acceleration of chondrogenic pathways.

This study examines the influences of PLIUS on adult articular chondrocytes cultured both in monolayer and within the well-established 3D agarose model. Initial studies investigated the effect of PLIUS intensity on the viability of chondrocytes within the agarose gel. Thereafter, two different intensities, 30 and 100 mW/cm^2^, were selected to test the hypothesis that PLIUS stimulates the synthesis and elaboration of sGAG over a 16-day culture period, and that this response is influenced by the intensity of the ultrasound. The synthesis of sGAG was quantified by measuring both the total sGAG content, using the DMB assay, and the synthesis of new sGAG, using incorporation of radiolabelled SO~4~.

Materials and methods {#Sec2}
=====================

Preparation of chondrocyte cultures {#Sec3}
-----------------------------------

Chondrocytes were isolated from the metacarpophalangeal joint of skeletally mature, 18--24 month old steers and seeded in agarose using a well-established method \[[@CR24]\]. Culture media (DMEM + 20% FCS) consisted of high glucose Dulbecco's Modified Eagles Medium (DMEM) supplemented with [l]{.smallcaps}-glutamine (2 μM), [l]{.smallcaps}-ascorbate (0.85 μM), penicillin (5 μg/ml), streptomycin (5 μg/ml), HEPES (20 mM) and 16.1% (v/v) foetal calf serum (FCS). All reagents were from Sigma-Aldrich UK, unless otherwise stated. Full depth cartilage from the proximal surface of the joint was extracted and sequentially digested at 37°C for 1 h in 700 units/ml of pronase (Type E, BDH Ltd., UK) followed by 16 h in 100 units/ml of collagenase (Type XI-A), both prepared in DMEM + FCS. The explant digest was passed through a cell sieve, and the resulting cell suspension was washed twice with fresh DMEM + FCS. Thereafter, cell number and viability were assessed using trypan blue and a haemocytometer. In total, data were collected from six separate chondrocyte isolations, with cells pooled from four to six individual joints for each isolation.

For 3D agarose cultures, the isolated cells were seeded in 3% low gelling agarose (type VII) at 4 × 10^6^ cells/ml. Using a positive displacement pipette, each well of a standard six-well culture plate was filled with 3.3 ml of the cell--agarose suspension to yield a layer of cell--agarose gel 3 mm in height. Subsequent to gelation at 4°C for 20 min, the cell--agarose layer in each well was covered with 6.6 ml of DMEM + FCS and cultured for 24 h at 37°C and 5% CO~2~ before experimentation. For monolayer cultures, cells were seeded directly into the wells of a standard six-well culture plate at a density of 100 × 10^3^ cells/cm^2^ as used previously \[[@CR35]\]. Each well, containing approximately 1 million cells, was filled with 6 ml of DMEM + FCS. All the cultures were maintained at 37°C and 5% CO~2~ within a humidified cell culture incubator with media changed every 1--3 days.

PLIUS system {#Sec4}
------------

PLIUS was generated using a calibrated Exogen system provided by Smith and Nephew Inc. (York, UK). This delivered an ultrasound signal with Spatial Average and Temporal Average (SATA) intensities between 30 and 300 mW/cm^2^, and a sinusoidal waveform of frequency of 1.5 MHz with a 200-μs pulse burst repeating at 1.0 kHz, as previously described \[[@CR33]\]. The ultrasonic driver box controlled six transducers mounted in a frame specifically for use with a standard six-well culture plate \[[@CR35]\]. PLIUS was produced at the transducers and transmitted through the bottom of the wells of a six-well plate with the use of coupling gel (Exogen, Piscataway, USA). For all the studies, PLIUS stimulation was applied once a day for a 20-min period.

Influence of PLIUS intensity on cell viability {#Sec5}
----------------------------------------------

Chondrocyte--agarose gels were cultured for 9 days, during which they were subjected to 20 min of PLIUS once a day at SATA intensities of either 30, 100, 200 or 300 mW/cm^2^. For assessment of cell viability, a single cylindrical construct, 6 mm in diameter, was removed from the central region of each well at the end of the 9-day culture period. The construct was cut longitudinally and incubated for 45 min in 0.6 ml of DMEM + FCS supplemented with Calcein-AM (5 μM, Molecular Probes, UK) and Ethidium homodimer-2 (5 μM, Molecular Probes, UK) to label the live and dead cells, respectively. Thereafter, each half construct was washed and mounted with its cut surface on a cover slip and visualised with a fluorescent microscope (Eclipse, Nikon, Kingston-upon-Thames, UK) with a ×20 objective. Viability was recorded by a systematic sampling of the construct, using a standard eye piece graticule sampling area of 0.5 × 0.25 mm^2^. Adjacent sampling areas were examined, profiling from the top of each construct down to the base closest to the PLIUS transducer. The number of live (green) and dead (red) cells were counted in each sampling area and the percentage viability calculated. The procedure was repeated (*n* = 3) for each construct.

Influence of PLIUS on sGAG production {#Sec6}
-------------------------------------

To quantify the influence of PLIUS on elaboration of sGAG, chondrocytes in both agarose and monolayer cultures were subjected daily, to a 20-min period of PLIUS at a SATA intensity of 30 or 100 mW/cm^2^. Initial exposure of the agarose constructs occurred after 24 h of culture. By contrast, monolayer cultures were first incubated for 96 h to enable cells to become fully attached to the plastic substrate, in keeping with previous studies by Parvezi et al*.* \[[@CR35]\]. Non-stimulated controls in separate six-well plates, were identically treated but without exposure to PLIUS.

Media were changed every 1--3 days and frozen for subsequent analysis. For agarose cultures, 6-mm-diameter cylindrical constructs (*n* = 6) were removed from the centre of a single well on days 1, 2, 5, 9, 12 and 16 and stored frozen. At the end of each experiment, the constructs were thawed and digested in 560 units/ml papain and 1000 units/ml agarase (both Sigma-Aldrich, Poole, UK). For monolayer cultures at days 4, 6 and 8, the media were removed, and the cell extract processed separately, following protocols described by Parvezi et al*.* \[[@CR35]\].

The entire procedure for both PLIUS intensity settings, was repeated using separate chondrocyte isolations (*n* = 3 for agarose and *n* = 2 for monolayer). At each time point, data was normalised to the corresponding controls to account for any inherent biological variation between the animals used in the replicate experiments.

Biochemical analysis {#Sec7}
--------------------

Total sGAG contents in the agarose constructs, the monolayer samples and all the associated media were determined using the DMB method \[[@CR11]\]. The sGAG values for the media were summed to give cumulative sGAG released into the media. In order to estimate the amount of sGAG released from each cylindrical agarose construct, the cummulative level of sGAG in the media for each well was multiplied by the ratio of the cross-sectional area of the agarose construct divided by the area of the well.

Radioisotope incorporation {#Sec8}
--------------------------

Radioisotope incorporation assays were used to determine the rate of sGAG synthesis over specific 24-h time periods following established protocols \[[@CR24]\]. For agarose constructs on days 1, 4, 8, 11 and 15, the media were removed from the wells and replaced with fresh media supplemented with 10 μCi/ml ^35^SO~4~ (Amersham Biosciences, UK). The media were removed after 24 h and stored frozen. After 24 h, 6-mm-diameter agarose constructs were removed, stored frozen until the end of the experiment and then digested with papain and agarase as described above. Similarly, for monolayer cultures ^35^SO~4~ supplement media were added at days 1, 4, 8, 11 and 15. After 24 h, the media and monolayer extract samples were removed and frozen before analysis.

Alcian blue precipitation onto filters (Millipore, Watford, UK) was used to determine the incorporation of ^35^SO~4~ into the newly synthesised sGAG in the agarose digest, the monolayer samples and all the associated media. The incorporation was normalised to the total DNA measurements calculated using the Hoescht 33258 assay as previously described \[[@CR1]\].

Results {#Sec9}
=======

Influence of PLIUS intensity on cell viability {#Sec10}
----------------------------------------------

After 9 days in culture, cell viability for agarose constructs was greater than 85% throughout the depth of the construct. PLIUS at SATA intensities of 30--100 mW/cm^2^ had no effect on cell viability (Fig. [1](#Fig1){ref-type="fig"}). However, at SATA intensities of 200 and 300 mW/cm^2^, a significant loss in viability occurred towards the bottom of the agarose constructs. Thus, at a SATA intensity of 300 mW/cm^2^, there was 100% cell death in the agarose, adjacent to the PLIUS transducer.Fig. 1Cell viability profiles through chondrocyte--agarose gels exposed to PLIUS for 20 min/day for 9 days. PLIUS was applied at SATA intensities of 30, 100, 200 and 300 mW/cm^2^. Controls were not exposed to PLIUS. Viability is expressed as the percentage of viable cells per field of view for adjacent fields of view throughout the 3 mm thickness of the agarose gel. Data points represent mean viability values (*n* = 6)

Influence of PLIUS on sGAG synthesis in agarose culture {#Sec11}
-------------------------------------------------------

The temporal change in total sGAG content are shown in Fig. [2](#Fig2){ref-type="fig"} for chondrocytes in agarose constructs exposed to PLIUS at 30 (Fig. [2](#Fig2){ref-type="fig"}a) and 100 mW/cm^2^ (Fig. [2](#Fig2){ref-type="fig"}b) with corresponding control values. Cummulative release of sGAG into the associated culture media is also presented. For all treatment groups, there was a steady synthesis of sGAG over the 16-day culture period, with approximately 80% retained within the agarose construct and the rest released to the associated culture media. Statistical analysis was conducted using the data from three repeat experiments and a total of 14 bovine joints. The application of PLIUS at a SATA intensity of 30 mW/cm^2^, showed no statistically significant effect on the total synthesis of sGAG or the retention within the agarose constructs at any of the time points (*P* \> 0.05, paired two-tailed *T*-test) (Fig. [2](#Fig2){ref-type="fig"}c). Similarly, at 100 mW/cm^2^, PLIUS had no effect with the exception of a 20% increase in total sGAG content at day 2 (*P* \< 0.05) (Fig. [2](#Fig2){ref-type="fig"}c).Fig. 2Effect of PLIUS on cumulative sGAG content produced by chondrocytes over a 16-day culture period in agarose. PLIUS was applied for 20 min each day from day 1. Data plotted separately for sGAG retained within agarose construct and released to associated culture media for control cells and those exposed to PLIUS at 30 (**a**) and 100 mW/cm^2^ (**b**). Data for PLIUS treated chondrocyte--agarose constructs has also been plotted as a percentage of that measured for corresponding untreated controls (**c**). Values represent mean ± standard deviation for three separate repeat experiments. Statistically significant differences are indicated at \* *P* \< 0.05

The incorporation of SO~4~ into newly synthesised sGAG for chondrocytes exposed to 30 and 100 mW/cm^2^ is presented graphically in Fig. [3](#Fig3){ref-type="fig"}. At days 2, 5, 9 and 16, but not day 12, SO~4~ incorporation over the previous 24 h was significantly reduced in cells exposed to 30 mW/cm^2^ PLIUS compared to controls (*P* \< 0.05). By contrast, PLIUS at 100 mW/cm^2^ was associated with statistically significant increases in SO~4~ incorporation measured at day 2 and day 16. At all other time points, differences were not statistically significant. Studies conducted with PLIUS applied twice a day showed no difference from the once-a-day protocol used here (data not shown) \[[@CR42]\].Fig. 3Effect of PLIUS at 30 and 100 mW/cm^2^ on SO~4~ incorporation over 24 h normalised to corresponding untreated controls (100%) for chondrocytes cultured in agarose for up to 16 days. PLIUS was applied for 20 min each day from day 1. Values represent mean ± standard deviation for 14 replicate specimens from two separate experiments. Statistically significant differences are indicated at \* *P* \< 0.05

Influence of PLIUS on sGAG synthesis in monolayer culture {#Sec12}
---------------------------------------------------------

Chondrocytes in monolayer synthesised sGAG, with the majority, approximately 50--70%, released to the media. There were no statistically significant differences, at any time point, in the total sGAG levels between control cultures and those exposed to PLIUS at either 30 or 100 mW/cm^2^ (Fig. [4](#Fig4){ref-type="fig"}). Similarly, PLIUS has no statistically significant effects on SO~4~ incorporation at any of the time points studied (Fig. [5](#Fig5){ref-type="fig"}).Fig. 4Effect of PLIUS at 30 and 100 mW/cm^2^ on total cumulative sGAG content (cell extract plus media) produced by chondrocytes over an 8-day culture period in monolayer. PLIUS was applied for 20 min each day from day 3. Data for PLIUS treated chondrocytes in monolayer has been plotted as a percentage of that measured for corresponding untreated controls. Values represent mean ± standard deviation for 12 replicate specimens from two separate experiments. There were no statistically significant differences between PLIUS-treated constructs and corresponding controlsFig. 5Effect of PLIUS at 30 and 100 mW/cm^2^ on SO~4~ incorporation over 24 h normalised to corresponding untreated controls (100%) for chondrocytes over an 8-day culture period in monolayer. PLIUS was applied for 20 min each day from day 3. Data for PLIUS treated chondrocytes in monolayer has been plotted as a percentage of that measured for corresponding untreated controls. Values represent mean ± standard deviation for 12 replicate specimens from two separate experiments. There were no statistically significant differences between PLIUS-treated constructs and corresponding controls

Discussion {#Sec13}
==========

The majority of previous studies examining the effects of PLIUS on chondrocytes have used monolayer cultures \[[@CR7], [@CR18], [@CR35], [@CR36]\]. However, such an approach has a number of biological and biophysical limitations. First, chondrocytes in monolayer are known to lose their chondrocytic phenotype and become more fibroblastic in nature, with associated alterations in cytoskeletal organisation and changes in matrix synthesis. In addition, monolayer cultures may be more susceptible to artefacts associated with PLIUS. For example, heating occurs due to attenuation of the ultrasound in the plastic encasing the transducers and the base of the cell culture six-well plate. Indeed, a previous study has reported a slight increase in the global temperature of the media within a single well \[[@CR14]\]. Whilst this temperature rise may not be sufficient to activate heat shock proteins or lead to cell death, it may alter the metabolism of the cells directly adhered to cell culture plastic. Another potential artefact with monolayer cultures is the development of standing waves caused by constructive interference associated with the reflection of the ultrasound between the air--media interface and the media--plastic interface \[[@CR14]\]. Standing waves may generate fluid shear forces, which are known to modulate chondrocyte metabolism and matrix synthesis \[[@CR23]\]. In addition, the reflection of the ultrasound signal back into the transducer may increase the heating effects. Thus, some studies have employed PLIUS systems in the absence of an air--media interface to ensure improved control of the ultrasound signal, as well as using ultrasound-absorbing material to eliminate multiple reflections \[[@CR15], [@CR19], [@CR30], [@CR46]\].

There is, therefore, increasing interest in understanding the effects of PLIUS on chondrocytes seeded within 3D scaffolds such as agarose, alginate and chitosan. Of these, the chondrocyte--agarose model has been particularly well characterised and is extensively used for examining the effect of mechanical stimulation on chondrocytes. Chondrocytes cultured in agarose adopt a rounded morphology necessary for the maintenance of chondrocytic phenotype, as shown by the synthesis of cartilage-specific aggrecan proteoglycan and type II collagen \[[@CR2], [@CR3]\]. For this reason, agarose has also been proposed as a scaffold for cartilage tissue engineering \[[@CR28], [@CR40]\] with encouraging clinical outcomes using chondrocytes embedded in a composite agarose-alginate hydrogel \[[@CR39]\]. Hence, this study investigated the effect of PLIUS on isolated chondrocytes seeded in agarose gel cast within a six-well plate mounted above an array of ultrasound transducers. The use of agarose is relevant both as a potential tissue-engineered scaffold and as a model for examining the therapeutic benefit of ultrasound for chondrocytes within a variety of 3D scaffolds proposed for cartilage tissue engineering. Comparative studies were also conducted using adult bovine chondrocytes cultured in monolayer following protocols described by Parvizi et al*.* \[[@CR35]\].

Previous studies investigating the influence of PLIUS have generally used a SATA intensity of 30 mW/cm^2^ which has been shown to be effective for treatment of bone fractures. However, modelling studies reveal that the exposure of knee joints to ultrasound at the clinical intensity of 30 mW/cm^2^ is likely to result in a tissue level intensity of only 10 mW/cm^2^ \[[@CR43]\]. Among those studies that report that PLIUS up-regulates chondrocyte metabolism, there is some disagreement as to whether intensity modulates this effect. Thus, some studies report a directly proportional relationship between intensity and cell activity \[[@CR6], [@CR17]\], others suggest that lower intensities are more effective \[[@CR40], [@CR46]\], while some other studies indicate little difference between intensity levels \[[@CR35]\] or no effect at all \[[@CR6], [@CR10]\]. This study demonstrated that viability in agarose was maintained at SATA intensities up to 100 mW/cm^2^, but was reduced at 200 and 300 mW/cm^2^, particularly for those cells located closer to the underlying ultrasound transducer (Fig. [1](#Fig1){ref-type="fig"}). This suggests that the cell death may be the result of attenuation heating in the transducer and/or the six-well plate, although other mechanisms, such as cavitation, cannot be excluded. Based on these results, all the subsequent studies were restricted to two intensity levels, namely 30 and 100 mW/cm^2^.

Preliminary studies found that PLIUS at either 30 or 100 mW/cm^2^ had no effect on cell proliferation in either monolayer or agarose cultures as assessed by total DNA content and incorporation of \[^3^H\]thymidine (data not shown) \[[@CR42]\]. This is in agreement with the majority of previous studies. In terms of the synthesis of sGAG, this study revealed that PLIUS at 30 mW/cm^2^ for 20 min/day, had no stimulatory effect on adult bovine articular chondrocytes cultured in either agarose gel (Figs. [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"}) or monolayer (Figs. [4](#Fig4){ref-type="fig"}, [5](#Fig5){ref-type="fig"}). Indeed, PLIUS significantly reduced the rate of SO~4~ incorporation for cell--agarose constructs at days 2, 5, 9 and 16, although this was not associated with a reduction in total sGAG content. At 100 mW/cm^2^ the application of PLIUS to cells in agarose only induced a statistically significant increase in SO~4~ incorporation with an associated increase in sGAG content, but only at day 2. For chondrocytes cultured in monolayer, PLIUS at 100 mW/cm^2^ had no effect on sGAG synthesis (Figs. [4](#Fig4){ref-type="fig"}, [5](#Fig5){ref-type="fig"}).

These findings are in agreement with a few previous studies suggesting that PLIUS has, at best, a minimal stimulatory effect on chondrocyte matrix production \[[@CR17], [@CR21], [@CR46]\]. However, the data appear to conflict with the other studies which suggest that ultrasound induces an up-regulation of chondrocyte aggrecan gene expression, incorporation of SO~4~ into the newly formed sGAG, and downstream sGAG accumulation \[[@CR21], [@CR33], [@CR35], [@CR40], [@CR44]\]. In particular, the pioneering study by Parvizi et al*.* \[[@CR35]\] is frequently cited as showing that PLIUS stimulates matrix production by rat chondrocytes in monolayer. However, in agreement with this study, Parvizi et al*.* report no statistically significant difference in sGAG content between PLIUS-treated and control cultures. This previous study did find a significant difference in the rate of change of sGAG content, but this appears to be due to the lower initial level of sGAG in the PLIUS treated samples. Nevertheless, in contrast to this study, similar experiments with bovine patella chondrocytes in monolayer show SO~4~ incorporation increased approximately twofold after 3--5 days of PLIUS exposure at 10 min/day \[[@CR20]\]. The difference may be due to the use of a higher ultrasound intensity of 580 mW/cm^2^, which did not result in cell death, possibly due to the use of a water bath system. The stimulatory effect in this and other studies might also be attributed to the utilisation of different cell types. Indeed, studies reporting a stimulatory effect of PLIUS have frequently employed neonatal, embryonic and mesenchymal stem cells (MSCs) \[[@CR9], [@CR32], [@CR46]\]. Such populations are likely to be more metabolically active than skeletally mature cells, such as those used in the present and other studies, which have reported minimal or no stimulatory effect of PLIUS \[[@CR6], [@CR10]\]. This is supported by studies showing that human articular chondrocytes from older donors are less responsive to PLIUS stimulation in agarose compared to cells from younger donors \[[@CR40]\]. However, the use of skeletally mature cells is relevant to the clinical situation, where the majority of patients seeking surgical intervention for cartilage injury are adults. Tissue engineering strategies would preferentially utilise autologous adult cells although an alternative approach might be to employ PLIUS to stimulate autologous MSCs into chondrogenesis. Indeed it has been reported that PLIUS enhances chondrogenic differentiation \[[@CR25]\] and stimulates proteoglycan and collagen expression for human MSCs cultured in 3D scaffolds \[[@CR38]\].

In this study, there was notable variation between replicate experiments with different cell isolations. Interestingly, Kopakkala-Tani et al*.* also reported that PLIUS induced different effects on cells from different animals \[[@CR20]\]. This variability may reflect important person to person variability in the benefit provided by any therapeutic approach using autologous cells. Although it is not clear as to what is responsible, one possibility is that ultrasound is only effective in tissue from a damaged or inflamed joint. This is supported by the fact that PLIUS is very effective in the treatment of fracture non-unions \[[@CR4], [@CR16], [@CR22]\], but has been shown to have no effect on increasing bone mass in osteoporosis where there is no injury response \[[@CR26]\]. Similarly, ultrasound is reported to have a greater effect on osteoarthritic human chondrocytes in monolayer compared to cells isolated from non-osteoarthric tissue from the same joint, although the study found no effect in cartilage explants \[[@CR21]\]. In addition, animal models show that PLIUS enhances healing of an osteochondral injury \[[@CR8]\] and reduces the severity and progression of osteoarthritis with an increase in collagen II gene expression \[[@CR13], [@CR31]\]. The mechanism may involve Rac1 and Wnt signalling which are activated by PLIUS and involved in membrane protrusion and cell migration associated with mammalian wound healing \[[@CR27], [@CR34]\]. Thus, as previously suggested, the therapeutic benefit of PLIUS, may be dependent on the presence of an injury or wound healing response involving Rac1-mediated cell migration. Indeed, this may explain the conflicting results from previous studies which might occur because of differing degrees of injury response present within different in vitro or in vivo model systems.

In conclusion, this study reveals that PLIUS at 30 mW/cm^2^ had no net effect on the synthesis of sGAG by adult bovine articular chondrocytes cultured in either agarose or monolayer culture. However, at 100 mW/cm^2^, PLIUS induced an initial transient up-regulation of SO~4~ incorporation and sGAG content in agarose constructs. This initial stimulatory effect of 100 mW/cm^2^ PLIUS, may be associated with some form of transient injury response caused by enzymatic isolation and seeding in agarose. This may provide a limited window of opportunity to stimulate sGAG production, at SATA intensities above 30 mW/cm^2^. These findings have important implications for the therapeutic potential of PLIUS for adult articular cartilage regeneration and tissue engineering as well as understanding the potential mechanisms through which PLIUS may activate a healing response in other systems.
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